Dimethylphenylpiperazinium
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
ChEMBL | |
Chemical and physical data | |
Formula | C12H19N2 |
Molar mass | 191.29 g/mol |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Dimethylphenylpiperazinium (DMPP) is a nicotinic acetylcholine receptor agonist which is selective for the ganglionic subtype.[1] One of the earliest reports on the pharmacology of DMPP, describing it as a ganglion-stimulating, hypertensive agent, came from Graham Chen and his co-workers at Parke, Davis & Co.[2]
See also
References
- ↑ Prado WA, Segalla DK (August 2004). "Antinociceptive effects of bethanechol or dimethylphenylpiperazinium in models of phasic or incisional pain in rats". Brain Res. 1018 (2): 272–82. PMID 15276888. doi:10.1016/j.brainres.2004.05.085.
- ↑ G. Chen, R. Portman and A. Wickel (1951) J. Pharmacol. Exp. Ther. 103 (1951).
Simple piperazines (no additional rings) | |
---|---|
Phenylpiperazines |
|
Benzylpiperazines | |
Diphenylalkylpiperazines (benzhydrylalkylpiperazines) |
|
Pyrimidinylpiperazines | |
Pyridinylpiperazines | |
Benzo(iso)thiazolylpiperazines | |
Tricyclics (piperazine attached via side chain) |
|
Others/Uncategorized |
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.